Lantheus Holdings, Inc. (LNTH)
|52 Week Range||47.46-100.851|
|1y Target Est||-|
|DCF Unlevered||LNTH DCF ->|
|DCF Levered||LNTH LDCF ->|
|Debt / Equity||106.92%||Buy|
Upgrades & Downgrades
Latest LNTH news
Investors Heavily Search Lantheus Holdings, Inc. (LNTH): Here is What You Need to Know
25 September 2023
Lantheus Holdings (LNTH) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
3 Stealth AI Stocks That Everyone Is Overlooking
21 September 2023
If you're putting together a list of overlooked AI stocks, I wouldn't try to sneak Nvidia (NASDAQ: NVDA ) on it. Even investor neophytes know about CEO Jensen Huang's obsession with artificial intelli...
3 AI Stocks That Should Be on Every Investor's Radar This Fall
20 September 2023
Artificial intelligence is still all the rage with investors, but the hype has pushed many stocks to unsustainable heights. Now that the irrational frenzy is cooling off, some compelling opportunities...
Strength Seen in Lantheus Holdings (LNTH): Can Its 6.4% Jump Turn into More Strength?
15 September 2023
Lantheus Holdings (LNTH) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price in...
Here is What to Know Beyond Why Lantheus Holdings, Inc. (LNTH) is a Trending Stock
12 September 2023
Recently, Zacks.com users have been paying close attention to Lantheus Holdings (LNTH). This makes it worthwhile to examine what the stock has in store.
Is the Options Market Predicting a Spike in Lantheus Holdings (LNTH) Stock?
30 August 2023
Investors need to pay close attention to Lantheus Holdings (LNTH) stock based on the movements in the options market lately.
Lantheus: Not Quite Ready To Take The Plunge
30 August 2023
Radiopharmacy is expected to experience exponential growth over the next decade. Radiopharmaceutical-based therapies offer more targeted and specific approaches for cancer treatment and medical imagin...
Lantheus Holdings, Inc. (LNTH) is Attracting Investor Attention: Here is What You Should Know
29 August 2023
Zacks.com users have recently been watching Lantheus Holdings (LNTH) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Lantheus Holdings (LNTH) Surpasses Q2 Earnings and Revenue Estimates
3 August 2023
Lantheus Holdings (LNTH) came out with quarterly earnings of $1.54 per share, beating the Zacks Consensus Estimate of $1.33 per share. This compares to earnings of $0.89 per share a year ago.
Lantheus to Host Second Quarter 2023 Earnings Conference Call and Webcast on August 3, 2023, at 8:00...
20 July 2023
BEDFORD, Mass., July 20, 2023 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH) today announced that it will host a conference call and webcast at 8:00 a.m. ET on Thursday, Au...